Ethyl 3-nitro-6-(trifluoromethyl)imidazo[1,2-a]pyridine-2-carboxylate

Catalog No.: 
ACDDYJ004
CAS No.: 
1171919-07-5
Molecular Formula: 
C11H8F3N3O4
Molecular Weight: 
303.20
Ethyl 3-nitro-6-(trifluoromethyl)imidazo[1,2-a]pyridine-2-carboxylate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$100.00InquiryInquiry
1g95%$295.00InquiryInquiry
5g95%$1446.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product NameEthyl 3-nitro-6-(trifluoromethyl)imidazo[1,2-a]pyridine-2-carboxylate
IUPAC Nameethyl 3-nitro-6-(trifluoromethyl)imidazo[1,2-a]pyridine-2-carboxylate
MDL No.MFCD12498712
Molecular FormulaC11H8F3N3O4
Molecular Weight303.20
SMILESO=C(C1=C([N+]([O-])=O)N2C=C(C(F)(F)F)C=CC2=N1)OCC
InChI KeyJMHLTIBQWGPJEG-UHFFFAOYSA-N
SynonymEthyl 3-nitro-6-(trifluoromethyl)imidazo-[1,2-a]pyridine-2-carboxylate;Imidazo[1,2-a]pyridine-2-carboxylic acid, 3-nitro-6-(trifluoromethyl)-, ethyl ester
CAS No.1171919-07-5

Synthetic Route by SureRoute

1. ACDDYJ004 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACTRMX927 route compound structure diagram
    ACTRMX927555-75-9
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACDDYJ004 route product structure diagram
    ACDDYJ0041171919-07-5
Inquiry

2. ACDDYJ004 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACDDYJ004 route product structure diagram
    ACDDYJ0041171919-07-5
Inquiry

3. ACDDYJ004 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACDDYJ004 route product structure diagram
    ACDDYJ0041171919-07-5
Inquiry

Comments (0)